Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetanus toxin peptide refers to a segment derived from the tetanus neurotoxin (TeNT), a potent protein toxin produced by the bacterium *Clostridium tetani*. The full-length tetanus neurotoxin is responsible for the clinical syndrome of tetanus and is one of the most powerful neurotoxins known. It inhibits neurotransmitter release, particularly of inhibitory neurotransmitters, leading to spastic paralysis. Specific peptide fragments are used in research for immunological studies, vaccine development, and investigating mechanisms of synaptic transmission. While the full toxin is highly dangerous, peptide fragments are generally used as research tools or vaccine components, having lower toxicity profiles.
The tetanus toxin light chain functions as a zinc-dependent endopeptidase, cleaving VAMP/synaptobrevin and blocking the release of inhibitory neurotransmitters (GABA and glycine) in the central nervous system.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetanus Neurotoxin Peptide (TeNT Peptide).